This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Insulin analogues

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • insulin analogues are available as:
    • short-acting analogues - insulin aspart and insulin lispro
      • short-acting analogues, insulin lispro and insulin aspart, in comparison to conventional human insulins, result in a small decrease in haemoglobin A1c levels in patients with type 1, but not type 2, diabetes mellitus (1)
      • the short-acting insulin analogues also appear to reduce the incidence of severe hypoglycaemia but not the overall likelihood of hypoglycaemia (1)
    • longer-acting analogues - insulin glargine and insulin detemir
      • both longer-acting insulin analogues seem to produce glycaemic control that is at least comparable to that with isophane insulin
      • insulin detemir seems to reduce nocturnal hypoglycaemia and result in less weight gain than does isophane insulin in patients with type 1 diabetes
      • insulin glargine appears to reduce nocturnal hypoglycaemia in patients with type 1 or type 2 diabetes
  • a review (1) concluded that there is no convincing evidence to justify switching patients from existing conventional therapy to analogues if they have appropriate glycaemic control without troublesome hypoglycaemia
  • long acting insulin analogues do not reduce HbA1c concentrations more than coventional human insulin but do reduce nocturnal hypoglycaemia (2)

Reference:

  • (1) Drug and Therapeutics Bulletin (2004); 42(10):77-80.
  • (2) Banerjee S et al. Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness. Technology Report 92.Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH); 2007.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.